Cargando…
Past and current perspective on new therapeutic targets for Type-II diabetes
Loss of pancreatic β-cell function is a hallmark of Type-II diabetes mellitus (DM). It is a chronic metabolic disorder that results from defects in both insulin secretion and insulin action. Recently, United Kingdom Prospective Diabetes Study reported that Type-II DM is a progressive disorder. Altho...
Autores principales: | Patil, Pradip D, Mahajan, Umesh B, Patil, Kalpesh R, Chaudhari, Sandip, Patil, Chandragouda R, Agrawal, Yogeeta O, Ojha, Shreesh, Goyal, Sameer N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446975/ https://www.ncbi.nlm.nih.gov/pubmed/28579755 http://dx.doi.org/10.2147/DDDT.S133453 |
Ejemplares similares
-
Ghrelin mediated regulation of neurosynaptic transmitters in depressive disorders
por: Masule, Milind V., et al.
Publicado: (2022) -
Protective Effects of Cardamom in Isoproterenol-Induced Myocardial Infarction in Rats
por: Goyal, Sameer N., et al.
Publicado: (2015) -
The Protective Effect of Apigenin on Myocardial Injury in Diabetic Rats mediating Activation of the PPAR-γ Pathway
por: Mahajan, Umesh B., et al.
Publicado: (2017) -
Ezetimibe-Loaded Nanostructured Lipid Carrier Based Formulation Ameliorates Hyperlipidaemia in an Experimental Model of High Fat Diet
por: Agrawal, Yogeeta O., et al.
Publicado: (2021) -
Animal Models of Inflammation for Screening of Anti-inflammatory Drugs: Implications for the Discovery and Development of Phytopharmaceuticals
por: Patil, Kalpesh R., et al.
Publicado: (2019)